Cleerly launches updated heart disease software

Cleerly has launched Cleerly 2.2.0, a new version of its software that includes user experience improvements and three new tools.

By staff writers
February 9, 2022

The new version features a quantitative comparison tool that tracks heart disease by the amount and type of atherosclerosis. The new technology also calculates the percentage of atheroma volume, enabling the quantification of the percentage of the vessel that is full of plaque. 

See full article HERE.

MedTech Strategist: Cleerly’s Personalized Approach to Heart Attack Risk

In this interview, Cleerly Founder and CEO, James Min, MD, shares how despite advances in cardiology, most heart attacks occur without warning....

Read More

Cleerly's AI scans comparable to gold-standard angiography

Only a few months after it emerged from stealth and burst onto the medtech scene, Cleerly is already living up to its name.

Read More

Cleerly’s Technology | An Important Impact On Our Overall Wellness

Health Tech: Dr James Min On How Cleerly’s Technology Can Make An Important Impact On Our Overall WellnessAn Interview With Dave Philistin

Read More